SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs informs about disclosure

04 Apr 2026 Evaluate
Aarti Pharmalabs has informed that it enclosed Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 02, 2026 for Renil Rajendra Gogri.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

750.00 -16.80 (-2.19%)
11-May-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.20
Dr. Reddys Lab 1291.90
Cipla 1314.05
Zydus Lifesciences 952.85
Lupin 2279.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×